Hepatic Injury from Paracetamol Overdose
Paracetamol (acetaminophen) overdose causes dose-dependent acute hepatocellular necrosis that can progress to acute liver failure (ALF), representing the leading cause of ALF in the United States and Europe, accounting for approximately 56% of severe acute liver injury cases. 1, 2
Mechanism of Liver Damage
The hepatotoxicity occurs through a specific metabolic pathway:
- Normal metabolism: At therapeutic doses, paracetamol is primarily metabolized via glucuronidation and sulfation
- Toxic pathway: A small fraction is metabolized by cytochrome P450 enzymes (primarily CYP2E1) to form the reactive metabolite N-acetyl-p-benzoquinone imine (NAPQI) 3
- Glutathione depletion: NAPQI is normally detoxified by conjugation with glutathione. In overdose, glutathione stores become depleted
- Protein binding: Once glutathione is depleted, NAPQI covalently binds to sulfhydryl groups of hepatocellular proteins, initiating cell death 3
- Hepatocellular necrosis: This results in centrilobular hepatic necrosis with massive elevation of aminotransferases (often >10,000 IU/L)
Clinical Presentation and Risk Stratification
The severity of hepatotoxicity directly correlates with the time to treatment initiation:
- <8 hours: Essentially no severe hepatotoxicity when N-acetylcysteine (NAC) is administered 4
- 8-10 hours: Minimal hepatotoxicity (one case of non-lethal injury in early studies) 4
- 10-16 hours: 29% develop severe hepatotoxicity 4
- 16-24 hours: 62% develop severe hepatotoxicity 4
- >24 hours: Substantially increased mortality risk 4
The Rumack-Matthew nomogram is the standard tool for risk stratification in acute single-time ingestions within 24 hours, plotting serum paracetamol concentration (drawn 4-24 hours post-ingestion) against time to determine hepatotoxicity risk 4.
Critical Distinction: Overdose Patterns
Unintentional overdoses carry significantly worse prognosis than intentional overdoses despite lower admission paracetamol concentrations (38.2% vs 25.6% mortality, p<0.001) 5. These patients are typically:
- Older
- More likely to abuse alcohol
- Taking compound narcotic/paracetamol preparations
- Present with greater organ dysfunction despite lower paracetamol levels
- Have reduced sensitivity to King's College prognostic criteria 5
Severity Thresholds
Per FDA labeling, severe liver damage may occur if 6:
- An adult takes >6 doses in 24 hours or >4000 mg total daily
- A child takes >5 doses in 24 hours
- Co-ingestion with alcohol (≥3 drinks daily)
- Co-ingestion with other acetaminophen-containing products
Treatment Implications
Administer NAC to all patients with possible or probable risk by the Rumack-Matthew nomogram, ideally within 8-10 hours post-ingestion (Level B recommendation) 4. This reduces severe hepatotoxicity incidence from 58% (historical controls) to 2.9% when given <8 hours 4.
For established hepatotoxicity or fulminant hepatic failure, NAC should still be administered regardless of time from ingestion (Level B recommendation) 4. Recent evidence suggests adjunctive therapies including fomepizole and calmangafodipir are under clinical development 3.
Common Pitfalls
- Delayed presentation: Patients presenting >24 hours post-ingestion cannot be risk-stratified by nomogram; treat based on detectable paracetamol levels and transaminase elevation 4
- Staggered/repeated supratherapeutic ingestions: Nomogram does not apply; assess based on clinical hepatotoxicity markers 4
- Extended-release formulations: Peak levels may be delayed beyond standard 4-hour window 7
- Combination products: Paracetamol may be difficult to identify in multi-ingredient preparations, leading to unintentional overdose 7
The key determinant of outcome is time to NAC administration—every hour of delay increases hepatotoxicity risk exponentially after 8 hours post-ingestion.